Aigen Investment Management’s Axonics, Inc. Common Stock AXNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-5,213
Closed -$324K 1077
2023
Q4
$324K Buy
+5,213
New +$292K 0.06% 462
2023
Q3
Sell
-26,959
Closed -$1.36M 1133
2023
Q2
$1.36M Buy
+26,959
New +$1.43M 0.2% 140
2023
Q1
Sell
-11,711
Closed -$732K 869
2022
Q4
$732K Buy
11,711
+8,100
+224% +$538K 0.1% 204
2022
Q3
$254K Buy
+3,611
New +$249K 0.04% 448
2021
Q4
Sell
-3,524
Closed -$229K 1211
2021
Q3
$229K Buy
+3,524
New +$241K 0.04% 396
2020
Q2
Sell
-512
Closed -$13K 1367
2020
Q1
$13K Buy
+512
New +$15.2K ﹤0.01% 1135

Other funds holding AXNX

Aigen Investment Management's AXNX Position: Q1 2024 in Review

Aigen Investment Management sold out of Axonics, Inc. Common Stock (AXNX) in Q1 2024, closing a stake of 5,213 shares — an estimated $324K sold.

Aigen Investment Management first reported a position in AXNX in Q1 2020 and held it in 6 quarters. The position peaked at $1.36M in Q2 2023. 235 funds tracked by Wall St. Rank hold AXNX as of Q1 2024.

  • Aigen Investment Management reported no remaining Axonics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Aigen Investment Management sold 5,213 Axonics, Inc. Common Stock shares in Q1 2024, an estimated $324K.
  • Aigen Investment Management first reported a position in Axonics, Inc. Common Stock in Q1 2020 and held it in 6 quarters.
  • Aigen Investment Management's Axonics, Inc. Common Stock position peaked at $1.36M in Q2 2023.
  • 235 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q1 2024.

Based on Aigen Investment Management's 13F filing for Q1 2024, filed 14 May 2024.